On 11 April 2022, the evaluating competent authority informed the Commission that the evaluation is delayed because studies are needed to assess the criteria for the determination of endocrine-disrupting properties of K-HDO. The evaluating competent authority expects to submit the renewal assessment report to the Agency in the first quarter of 2025.
Recital 7, Decision_act (EU) 2022/1488
In forcesince 7 Sep 2022